non-small cell lung cancer

Coherus Bio climbs on positive toripalimab combo results in late-stage lung cancer study
Seeking Alpha
Thu, 08/19/21 - 11:00 am
Coherus Biosciences
Shanghai Junshi Biosciences
clinical trials
toripalimab
non-small cell lung cancer
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Benzinga
Fri, 08/6/21 - 11:16 am
Innovent Biologics
Eli Lilly
sintilimab
clinical trials
non-small cell lung cancer
#ASCO21: AstraZeneca's PD-1 Imfinzi tacks on 5-year survival data in NSCLC, which it's calling 'unprecedented'
Endpoints
Fri, 06/4/21 - 10:48 am
ASCO 2021
AstraZeneca
non-small cell lung cancer
Imfinzi
Guardant’s Partnership with Janssen Bears Fruit
Medical Devices and Diagnostics Industry
Mon, 05/24/21 - 11:25 pm
Guardant Health
Janssen
liquid biopsies
FDA
Guardant 360 CDx
Rybrevant
non-small cell lung cancer
diagnostics
J&J beats Tagrisso and Takeda to the punch in key NSCLC subset, picking up new FDA approval
Endpoints
Sun, 05/23/21 - 03:08 pm
JNJ
non-small cell lung cancer
Janssen
amivantamab
FDA
#ASCO21: J&J busts out a small update for its antibody-TKI combo in lung cancer — whetting appetites as FDA thinks it over
Endpoints
Thu, 05/20/21 - 12:21 pm
ASCO 2021
JNJ
amivantamab
non-small cell lung cancer
Takeda fleshes out case for oral EGFR drug with follow-up pivotal data in non-small cell lung cancer
Endpoints
Wed, 05/19/21 - 11:14 pm
ASCO 2021
lung cancer
Takeda
FDA
non-small cell lung cancer
AACR: OncoMyx's engineered rabbit pox virus shows promise in lung cancer model
Fierce Biotech
Mon, 04/12/21 - 10:57 am
AACR
OncoMyx
rabbit pox
non-small cell lung cancer
Roche's Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors use it?
Fierce Pharma
Mon, 03/22/21 - 10:48 am
Roche
Tecentriq
non-small cell lung cancer
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda
Fierce Pharma
Thu, 03/4/21 - 11:21 pm
Pfizer
Lorbrena
non-small cell lung cancer
Novartis
Roche
Takeda
Libtayo scores second OK in two weeks, this time for front-line NSCLC. Can it take on Keytruda?
Endpoints
Mon, 02/22/21 - 11:51 pm
Regeneron
Libtayo
non-small cell lung cancer
Merck
Keytruda
Novartis’s canakinumab cancer test approaches
EP Vantage
Fri, 02/12/21 - 11:06 am
Novartis
Regeneron
canakinumab
cancer
non-small cell lung cancer
Merck's Keytruda Proves Better Alone in Combination Trial With BMS' Yervoy
BioSpace
Mon, 02/1/21 - 11:12 pm
Merck
Keytruda
Bristol-Myers Squibb
Yervoy
non-small cell lung cancer
J&J pushes new amivantamab data for NSCLC subset, trying to bolster case for quick FDA approval
Endpoints
Thu, 01/28/21 - 11:16 pm
JNJ
amivantamab
non-small cell lung cancer
Takeda earns win for its TKI inhibitor in tiny lung cancer group — but GI side effects could be an early red flag
Endpoints
Thu, 01/28/21 - 10:41 am
Takeda
lung cancer
mobocertinib
non-small cell lung cancer
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq
Pharmaceutical Business Review
Wed, 01/6/21 - 10:37 am
Roche
FDA
tiragolumab
Tecentriq
non-small cell lung cancer
breakthrough therapies
Best-selling Tagrisso further outpaces an upcoming J&J rival, winning approval in new NSCLC indication
Endpoints
Mon, 12/21/20 - 10:59 am
AstraZeneca
Tagrisso
non-small cell lung cancer
JNJ
amivantamab
In a first, Janssen submits lung cancer bispecific hopeful amivantamab to the FDA
Fierce Biotech
Thu, 12/3/20 - 10:55 am
Janssen
non-small cell lung cancer
FDA
amivantamab
JNJ
metastatic non-small cell lung cancer
Merck pulls the plug on a study evaluating blockbuster Keytruda with Yervoy for NSCLC
Endpoints
Tue, 11/10/20 - 10:45 am
Merck
Keytruda
Yervoy
clinical trials
non-small cell lung cancer
Jounce shares crash after it abandons immunotherapy combination trial
Pharmaforum
Tue, 11/3/20 - 10:24 am
Jounce Therapeutics
non-small cell lung cancer
Bristol-Myers Squibb
Yervoy

Pages